Leerink Swann reaffirmed their outperform rating on shares of Intuitive Surgical Inc. (NASDAQ:ISRG) in a research report sent to investors on Monday morning. Leerink Swann currently has a $780.00 price objective on the stock.

A number of other research firms have also weighed in on ISRG. Barclays PLC restated a buy rating on shares of Intuitive Surgical in a research report on Saturday, June 18th. Citigroup Inc. restated a buy rating on shares of Intuitive Surgical in a research report on Thursday, June 2nd. JPMorgan Chase & Co. restated a buy rating on shares of Intuitive Surgical in a research report on Thursday, June 2nd. Piper Jaffray Cos. restated a neutral rating and set a $700.00 price target (up from $610.00) on shares of Intuitive Surgical in a research report on Wednesday, July 20th. Finally, BTIG Research restated a neutral rating on shares of Intuitive Surgical in a research report on Wednesday, July 20th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have given a buy rating to the stock. Intuitive Surgical has an average rating of Buy and a consensus price target of $701.42.

Intuitive Surgical (NASDAQ:ISRG) opened at 703.06 on Monday. The stock’s 50 day moving average is $688.84 and its 200-day moving average is $648.41. The stock has a market capitalization of $27.06 billion, a price-to-earnings ratio of 39.90 and a beta of 0.73. Intuitive Surgical has a 12 month low of $447.00 and a 12 month high of $720.01.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, July 19th. The company reported $5.62 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.65. The business earned $670 million during the quarter, compared to analysts’ expectations of $640.69 million. Intuitive Surgical had a net margin of 26.80% and a return on equity of 15.25%. During the same quarter in the previous year, the company earned $4.57 earnings per share. On average, equities research analysts expect that Intuitive Surgical will post $21.30 earnings per share for the current year.

In other Intuitive Surgical news, CEO Gary S. Guthart sold 13,400 shares of the stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $698.00, for a total value of $9,353,200.00. Following the sale, the chief executive officer now directly owns 78,780 shares of the company’s stock, valued at approximately $54,988,440. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Marshall Mohr sold 5,000 shares of the stock in a transaction that occurred on Wednesday, July 27th. The shares were sold at an average price of $684.09, for a total transaction of $3,420,450.00. Following the completion of the sale, the chief financial officer now directly owns 6,725 shares in the company, valued at $4,600,505.25. The disclosure for this sale can be found here. Corporate insiders own 3.10% of the company’s stock.

Several large investors have recently made changes to their positions in ISRG. Global X Management Co. LLC purchased a new stake in shares of Intuitive Surgical during the second quarter worth approximately $118,000. Acrospire Investment Management LLC purchased a new stake in shares of Intuitive Surgical during the first quarter worth approximately $120,000. Bartlett & Co. LLC increased its stake in shares of Intuitive Surgical by 7.3% in the second quarter. Bartlett & Co. LLC now owns 220 shares of the company’s stock worth $146,000 after buying an additional 15 shares in the last quarter. Glenmede Trust Co. NA increased its stake in shares of Intuitive Surgical by 3.0% in the second quarter. Glenmede Trust Co. NA now owns 275 shares of the company’s stock worth $181,000 after buying an additional 8 shares in the last quarter. Finally, IFP Advisors Inc increased its stake in shares of Intuitive Surgical by 3.3% in the first quarter. IFP Advisors Inc now owns 284 shares of the company’s stock worth $171,000 after buying an additional 9 shares in the last quarter. 91.90% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.